vs

Side-by-side financial comparison of AEMETIS, INC (AMTX) and Gevo, Inc. (GEVO). Click either name above to swap in a different company.

Gevo, Inc. is the larger business by last-quarter revenue ($45.3M vs $43.3M, roughly 1.0× AEMETIS, INC). On growth, Gevo, Inc. posted the faster year-over-year revenue change (695.6% vs -7.9%). Gevo, Inc. produced more free cash flow last quarter ($8.7M vs $-10.8M). Over the past eight quarters, Gevo, Inc.'s revenue compounded faster (237.1% CAGR vs -22.8%).

Aemetis, Inc. is a renewable fuels and sustainable biochemicals producer operating across North America and India. Its core products include low-carbon ethanol, renewable natural gas and biodiesel, serving transportation, industrial and agricultural sectors with decarbonization solutions for commercial clients.

Gevo, Inc. is an American renewable chemicals and advanced biofuels company headquartered in unincorporated Douglas County, Colorado, in the Denver-Aurora metropolitan area. Gevo operates in the sustainability sector, pursuing a business model based on the concept of the "circular economy". The company develops bio-based alternatives to petroleum-based products using a combination of biotechnology and classical chemistry. Gevo uses the GREET model from Argonne National Laboratory as a basis f...

AMTX vs GEVO — Head-to-Head

Bigger by revenue
GEVO
GEVO
1.0× larger
GEVO
$45.3M
$43.3M
AMTX
Growing faster (revenue YoY)
GEVO
GEVO
+703.4% gap
GEVO
695.6%
-7.9%
AMTX
More free cash flow
GEVO
GEVO
$19.5M more FCF
GEVO
$8.7M
$-10.8M
AMTX
Faster 2-yr revenue CAGR
GEVO
GEVO
Annualised
GEVO
237.1%
-22.8%
AMTX

Income Statement — Q4 2025 vs Q4 2025

Metric
AMTX
AMTX
GEVO
GEVO
Revenue
$43.3M
$45.3M
Net Profit
$-6.0M
Gross Margin
17.8%
Operating Margin
-5.7%
-4.8%
Net Margin
-13.2%
Revenue YoY
-7.9%
695.6%
Net Profit YoY
65.9%
EPS (diluted)
$-0.03
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMTX
AMTX
GEVO
GEVO
Q4 25
$43.3M
$45.3M
Q3 25
$59.2M
$42.7M
Q2 25
$52.2M
$43.4M
Q1 25
$42.9M
$29.1M
Q4 24
$47.0M
$5.7M
Q3 24
$81.4M
$2.0M
Q2 24
$66.6M
$5.3M
Q1 24
$72.6M
$4.0M
Net Profit
AMTX
AMTX
GEVO
GEVO
Q4 25
$-6.0M
Q3 25
$-23.7M
$-8.0M
Q2 25
$-23.4M
$2.1M
Q1 25
$-24.5M
$-21.7M
Q4 24
$-17.6M
Q3 24
$-17.9M
$-21.2M
Q2 24
$-29.2M
$-21.0M
Q1 24
$-24.2M
$-18.9M
Gross Margin
AMTX
AMTX
GEVO
GEVO
Q4 25
17.8%
Q3 25
-0.1%
Q2 25
-6.4%
Q1 25
-11.8%
Q4 24
-4.3%
Q3 24
4.8%
Q2 24
-2.7%
Q1 24
-0.8%
Operating Margin
AMTX
AMTX
GEVO
GEVO
Q4 25
-5.7%
-4.8%
Q3 25
-14.4%
-8.6%
Q2 25
-20.4%
13.4%
Q1 25
-36.3%
-69.2%
Q4 24
-28.7%
-344.7%
Q3 24
-4.8%
-1221.8%
Q2 24
-20.4%
-456.8%
Q1 24
-13.0%
-580.0%
Net Margin
AMTX
AMTX
GEVO
GEVO
Q4 25
-13.2%
Q3 25
-40.1%
-18.6%
Q2 25
-44.8%
4.9%
Q1 25
-57.2%
-74.6%
Q4 24
-308.9%
Q3 24
-22.0%
-1076.6%
Q2 24
-43.8%
-399.3%
Q1 24
-33.4%
-473.1%
EPS (diluted)
AMTX
AMTX
GEVO
GEVO
Q4 25
$-0.03
$-0.03
Q3 25
$-0.37
$-0.03
Q2 25
$-0.41
$0.01
Q1 25
$-0.47
$-0.09
Q4 24
$-0.29
$-0.08
Q3 24
$-0.38
$-0.09
Q2 24
$-0.66
$-0.09
Q1 24
$-0.58
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMTX
AMTX
GEVO
GEVO
Cash + ST InvestmentsLiquidity on hand
$4.9M
$81.2M
Total DebtLower is stronger
$164.8M
Stockholders' EquityBook value
$-306.8M
$466.3M
Total Assets
$259.8M
$718.9M
Debt / EquityLower = less leverage
0.35×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMTX
AMTX
GEVO
GEVO
Q4 25
$4.9M
$81.2M
Q3 25
$5.6M
$72.6M
Q2 25
$1.6M
$57.3M
Q1 25
$499.0K
$65.3M
Q4 24
$898.0K
$189.4M
Q3 24
$296.0K
$223.2M
Q2 24
$234.0K
$245.7M
Q1 24
$1.6M
$270.6M
Total Debt
AMTX
AMTX
GEVO
GEVO
Q4 25
$164.8M
Q3 25
$164.5M
Q2 25
$167.5M
Q1 25
$167.0M
Q4 24
$338.1M
$67.1M
Q3 24
$322.2M
$67.0M
Q2 24
$309.0M
$66.8M
Q1 24
$307.2M
$68.3M
Stockholders' Equity
AMTX
AMTX
GEVO
GEVO
Q4 25
$-306.8M
$466.3M
Q3 25
$-304.9M
$468.9M
Q2 25
$-289.3M
$474.1M
Q1 25
$-280.7M
$469.8M
Q4 24
$-263.9M
$489.5M
Q3 24
$-258.9M
$504.7M
Q2 24
$-249.0M
$522.7M
Q1 24
$-232.1M
$541.9M
Total Assets
AMTX
AMTX
GEVO
GEVO
Q4 25
$259.8M
$718.9M
Q3 25
$241.1M
$685.2M
Q2 25
$240.0M
$702.1M
Q1 25
$242.5M
$677.8M
Q4 24
$259.3M
$583.9M
Q3 24
$259.3M
$583.9M
Q2 24
$259.3M
$617.9M
Q1 24
$259.3M
$633.6M
Debt / Equity
AMTX
AMTX
GEVO
GEVO
Q4 25
0.35×
Q3 25
0.35×
Q2 25
0.35×
Q1 25
0.36×
Q4 24
0.14×
Q3 24
0.13×
Q2 24
0.13×
Q1 24
0.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMTX
AMTX
GEVO
GEVO
Operating Cash FlowLast quarter
$5.8M
$20.0M
Free Cash FlowOCF − Capex
$-10.8M
$8.7M
FCF MarginFCF / Revenue
-24.9%
19.3%
Capex IntensityCapex / Revenue
38.2%
24.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-22.7M
$-43.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMTX
AMTX
GEVO
GEVO
Q4 25
$5.8M
$20.0M
Q3 25
$3.1M
$-6.8M
Q2 25
$-5.7M
$-2.5M
Q1 25
$160.0K
$-24.0M
Q4 24
$-12.6M
$-18.8M
Q3 24
$-5.0M
$-11.0M
Q2 24
$-5.1M
$-11.4M
Q1 24
$-10.3M
$-16.1M
Free Cash Flow
AMTX
AMTX
GEVO
GEVO
Q4 25
$-10.8M
$8.7M
Q3 25
$-1.0M
$-14.6M
Q2 25
$-9.3M
$-7.8M
Q1 25
$-1.7M
$-29.9M
Q4 24
$-19.4M
$-33.5M
Q3 24
$-9.5M
$-20.8M
Q2 24
$-10.5M
$-20.6M
Q1 24
$-13.9M
$-33.6M
FCF Margin
AMTX
AMTX
GEVO
GEVO
Q4 25
-24.9%
19.3%
Q3 25
-1.7%
-34.2%
Q2 25
-17.7%
-17.9%
Q1 25
-3.9%
-102.7%
Q4 24
-41.2%
-587.2%
Q3 24
-11.6%
-1057.0%
Q2 24
-15.8%
-392.4%
Q1 24
-19.1%
-841.9%
Capex Intensity
AMTX
AMTX
GEVO
GEVO
Q4 25
38.2%
24.7%
Q3 25
6.9%
18.3%
Q2 25
6.7%
12.1%
Q1 25
4.3%
20.0%
Q4 24
14.4%
256.6%
Q3 24
5.5%
496.2%
Q2 24
8.1%
174.8%
Q1 24
4.9%
438.9%
Cash Conversion
AMTX
AMTX
GEVO
GEVO
Q4 25
Q3 25
Q2 25
-1.18×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMTX
AMTX

Ethanol Sales$28.8M66%
Wet Distillers Grains$6.8M16%
California Dairy Renewable Natural Gas$5.2M12%
Other$1.8M4%

GEVO
GEVO

Segment breakdown not available.

Related Comparisons